Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study
Table 4
Likelihood of being prescribed any antidepressant medication by co-morbidity ().
Co-morbid condition
Patients who were prescribed an antidepressant
Likelihood of being prescribed antidepressant
Patients with co-morbidity
Patients without co-morbidity
Unadjusted OR
Model 1 Adjusted OR1 (95% CI)
Model 2 Adjusted OR1 (95% CI)
(%)
(%)
Coronary heart disease
84/202 (41.6)
749/2242 (33.4)
1.419 (1.058–1.903)*
1.028 (0.753–1.404)
1.191 (0.864–1.643)
Cerebrovascular disease
56/99 (56.6)
777/2345 (33.1)
2.628 (1.750–3.947)*
1.781 (1.159–2.739)*
1.762 (1.124–2.762)*
Diabetes mellitus
82/174 (47.1)
751/2270 (33.1)
1.803 (1.322–2.459)*
1.342 (0.968–1.860)
1.317 (0.936–1.855)
Cancer
108/351 (30.8)
725/2093 (34.6)
0.829 (0.657–1.070)
0.652 (0.505–0.842)*
0.745 (0.572–0.969)*
Congestive heart failure
59/113 (52.2)
774/2331 (33.2)
2.198 (1.504–3.211)*
1.431 (0.951–2.154)
1.652 (1.082–2.521)*
Chronic obstructive Pulmonary disease
34/68 (50.0)
799/2376 (33.6)
1.974 (1.218–3.199)*
1.612 (0.986–2.638)
1.950 (1.188–3.200)*
Any comorbidity
267/708 (37.7)
566/1736 (32.6)
1.252 (1.043–1.502)*
0.878 (0.709–1.086)
1.007 (0.807–1.257)
1Odds ratio for patients who had a co-morbidity compared to patients who did not have co-morbidity. Model 1: adjusted for patient age and gender. Model 2: adjusted for patient age and gender, as well as for physician specialisation and type of depression.